Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September
September 08 2020 - 8:00AM
Business Wire
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical
company focused on the discovery, development and commercialization
of innovative therapies for diseases of the eye, today announced
that members of its management team will participate virtually in
the following upcoming conferences:
H.C. Wainwright 22nd Annual Global Investment Conference
Date: Monday, September 14, 2020 Presentation Time: 1:00 p.m.
ET
2020 Cantor Global Healthcare Conference Date: Tuesday,
September 15, 2020 Presentation Time: 10:40 a.m. ET
Oppenheimer Fall Healthcare Life Sciences & MedTech
Summit Date: Monday, September 21, 2020 Fireside Chat Time:
2:30 p.m. ET
To access a live webcast and subsequent archived recording of
each presentation, please visit “Events” in the “Investors” section
of the Kala website at http://kalarx.com.
About Kala Pharmaceuticals, Inc.
Kala is a biopharmaceutical company focused on the discovery,
development and commercialization of innovative therapies for
diseases of the eye. Kala has applied its AMPPLIFY® mucus
penetrating particle Drug Delivery Technology to a corticosteroid,
loteprednol etabonate (LE), designed for ocular applications,
resulting in the January 2019 launch of INVELTYS® (loteprednol
etabonate ophthalmic suspension) 1% and its investigational product
candidate, EYSUVISTM (loteprednol etabonate ophthalmic suspension)
0.25%, for which a New Drug Application (NDA) is under review by
the United States Food and Drug Administration (FDA) with a
Prescription Drug User Fee Act (PDUFA) goal date set for October
30, 2020.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200908005028/en/
Hannah Deresiewicz hannah.deresiewicz@sternir.com
212-362-1200
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Aug 2024 to Sep 2024
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Sep 2023 to Sep 2024